The House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) have announced a hearing titled “Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices.” They stated that America is a leader in developing cutting-edge biomedical innovation, with countries around the globe looking to the FDA for guidance on safe and effective treatments and medical devices.
The Subcommittee on Health hearing is scheduled for Wednesday, May 22, 2024, at 10:30 AM ET at 2322 Rayburn House Office Building. The hearing will focus on discussing the FDA’s regulation of drugs, biologics, and devices. Witnesses at the hearing include Dr. Patrizia Cavazzoni, Director of the Center for Drug Evaluation and Research (CDER) at the FDA, Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, and Dr. Jeffrey Shuren, Director of the Center for Devices and Radiological Health (CDRH) at the FDA.
The committee staff can be reached for questions related to the hearing through Emma Schultheis at Emma.Schultheis@mail.house.gov. Press-related queries should be directed to Christopher Krepich at Christopher.Krepich@mail.house.gov.[The hearing will be open to